
Global Medical Device Podcast powered by Greenlight Guru
#350: The Evolving Landscape of AI in MedTech
Jan 4, 2024
Eric Henry, AI in MedTech expert, and Etienne Nichols discuss the evolving landscape of AI in MedTech, focusing on regulatory compliance and the future of AI in medical devices. They explore the role of FDA and FTC, the implications of generative AI, and the potential revolution in quality management systems. The FTC's growing role and algorithmic disgorgement are highlighted, along with the importance of pre-market and post-market oversight.
49:20
Episode guests
AI Summary
Highlights
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- FTC may have broader enforcement authority over AI in various industries.
- AI is set to revolutionize quality management systems and manufacturing processes in the life sciences.
Deep dives
Regulatory Authority of the FTC in AI Enforcement
The Federal Trade Commission (FTC) has enforcement authority over artificial intelligence across industries in the United States. Proposed legislation aims to broaden their enforcement authority. The FTC has used enforcement tools in other industries to impose fines and delete algorithms and associated data with a tool called Algorithmic Discouragement. Companies in the medical device and life sciences industry should keep an eye on the FTC and their actions as they may start using their enforcement tools in this sector.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.